Naive human T cells are produced and developed in the thymus, which atrophies abruptly and severely in response to physical or psychological stress. To understand how an instance of stress affects the size and "diversity" of the peripheral naive T cell pool, we derive a mean-field autonomous ODE model of T cell replenishment that allows us to track the clone abundance distribution (the mean number of different TCRs each represented by a specific number of cells). We identify equilibrium solutions that arise at different rates of T cell production, and derive analytic approximations to the dominant eigenvalues and eigenvectors of the mathematical model linearized about these equilibria. From the forms of the eigenvalues and eigenvectors, we estimate rates at which counts of clones of different sizes converge to and depart from equilibrium values-that is, how the number of clones of different sizes "adjusts" to the changing rate of T cell production. Under most physiological realizations of our model, the dominant eigenvalue (representing the slowest dynamics of the clone abundance distribution) scales as a power law in the thymic output for low output levels, but saturates at higher T cell production rates. Our analysis provides a framework for quantitatively understanding how the clone abundance distribution evolves under small changes in the overall T cell production rate.
Citation: Stephanie M. Lewkiewicz, Yao-Li Chuang, Tom Chou. Dynamics of T cell receptor distributions following acute thymic atrophy and resumption[J]. Mathematical Biosciences and Engineering, 2020, 17(1): 28-55. doi: 10.3934/mbe.2020002
[1] | Minlong Lin, Ke Tang . Selective further learning of hybrid ensemble for class imbalanced increment learning. Big Data and Information Analytics, 2017, 2(1): 1-21. doi: 10.3934/bdia.2017005 |
[2] | Subrata Dasgupta . Disentangling data, information and knowledge. Big Data and Information Analytics, 2016, 1(4): 377-390. doi: 10.3934/bdia.2016016 |
[3] | Qinglei Zhang, Wenying Feng . Detecting Coalition Attacks in Online Advertising: A hybrid data mining approach. Big Data and Information Analytics, 2016, 1(2): 227-245. doi: 10.3934/bdia.2016006 |
[4] | Tieliang Gong, Qian Zhao, Deyu Meng, Zongben Xu . Why Curriculum Learning & Self-paced Learning Work in Big/Noisy Data: A Theoretical Perspective. Big Data and Information Analytics, 2016, 1(1): 111-127. doi: 10.3934/bdia.2016.1.111 |
[5] | Xin Yun, Myung Hwan Chun . The impact of personalized recommendation on purchase intention under the background of big data. Big Data and Information Analytics, 2024, 8(0): 80-108. doi: 10.3934/bdia.2024005 |
[6] | Pankaj Sharma, David Baglee, Jaime Campos, Erkki Jantunen . Big data collection and analysis for manufacturing organisations. Big Data and Information Analytics, 2017, 2(2): 127-139. doi: 10.3934/bdia.2017002 |
[7] | Zhen Mei . Manifold Data Mining Helps Businesses Grow More Effectively. Big Data and Information Analytics, 2016, 1(2): 275-276. doi: 10.3934/bdia.2016009 |
[8] | Ricky Fok, Agnieszka Lasek, Jiye Li, Aijun An . Modeling daily guest count prediction. Big Data and Information Analytics, 2016, 1(4): 299-308. doi: 10.3934/bdia.2016012 |
[9] | M Supriya, AJ Deepa . Machine learning approach on healthcare big data: a review. Big Data and Information Analytics, 2020, 5(1): 58-75. doi: 10.3934/bdia.2020005 |
[10] | Sunmoo Yoon, Maria Patrao, Debbie Schauer, Jose Gutierrez . Prediction Models for Burden of Caregivers Applying Data Mining Techniques. Big Data and Information Analytics, 2017, 2(3): 209-217. doi: 10.3934/bdia.2017014 |
Naive human T cells are produced and developed in the thymus, which atrophies abruptly and severely in response to physical or psychological stress. To understand how an instance of stress affects the size and "diversity" of the peripheral naive T cell pool, we derive a mean-field autonomous ODE model of T cell replenishment that allows us to track the clone abundance distribution (the mean number of different TCRs each represented by a specific number of cells). We identify equilibrium solutions that arise at different rates of T cell production, and derive analytic approximations to the dominant eigenvalues and eigenvectors of the mathematical model linearized about these equilibria. From the forms of the eigenvalues and eigenvectors, we estimate rates at which counts of clones of different sizes converge to and depart from equilibrium values-that is, how the number of clones of different sizes "adjusts" to the changing rate of T cell production. Under most physiological realizations of our model, the dominant eigenvalue (representing the slowest dynamics of the clone abundance distribution) scales as a power law in the thymic output for low output levels, but saturates at higher T cell production rates. Our analysis provides a framework for quantitatively understanding how the clone abundance distribution evolves under small changes in the overall T cell production rate.
For a continuous risk outcome
Given fixed effects
In this paper, we assume that the risk outcome
y=Φ(a0+a1x1+⋯+akxk+bs), | (1.1) |
where
Given random effect model (1.1), the expected value
We introduce a family of interval distributions based on variable transformations. Probability densities for these distributions are provided (Proposition 2.1). Parameters of model (1.1) can then be estimated by maximum likelihood approaches assuming an interval distribution. In some cases, these parameters get an analytical solution without the needs for a model fitting (Proposition 4.1). We call a model with a random effect, where parameters are estimated by maximum likelihood assuming an interval distribution, an interval distribution model.
In its simplest form, the interval distribution model
The paper is organized as follows: in section 2, we introduce a family of interval distributions. A measure for tail fatness is defined. In section 3, we show examples of interval distributions and investigate their tail behaviours. We propose in section 4 an algorithm for estimating the parameters in model (1.1).
Interval distributions introduced in this section are defined for a risk outcome over a finite open interval
Let
Let
Φ:D→(c0,c1) | (2.1) |
be a transformation with continuous and positive derivatives
Given a continuous random variable
y=Φ(a+bs), | (2.2) |
where we assume that the range of variable
Proposition 2.1. Given
g(y,a,b)=U1/(bU2) | (2.3) |
G(y,a,b)=F[Φ−1(y)−ab]. | (2.4) |
where
U1=f{[Φ−1(y)−a]/b},U2=ϕ[Φ−1(y)] | (2.5) |
Proof. A proof for the case when
G(y,a,b)=P[Φ(a+bs)≤y] |
=P{s≤[Φ−1(y)−a]/b} |
=F{[Φ−1(y)−a]/b}. |
By chain rule and the relationship
∂Φ−1(y)∂y=1ϕ[Φ−1(y)]. | (2.6) |
Taking the derivative of
∂G(y,a,b)∂y=f{[Φ−1(y)−a]/b}bϕ[Φ−1(y)]=U1bU2. |
One can explore into these interval distributions for their shapes, including skewness and modality. For stress testing purposes, we are more interested in tail risk behaviours for these distributions.
Recall that, for a variable X over (−
For a risk outcome over a finite interval
We say that an interval distribution has a fat right tail if the limit
Given
Recall that, for a Beta distribution with parameters
Next, because the derivative of
z=Φ−1(y) | (2.7) |
Then
Lemma 2.2. Given
(ⅰ)
(ⅱ) If
(ⅲ) If
Proof. The first statement follows from the relationship
[g(y,a,b)(y1−y)β]−1/β=[g(y,a,b)]−1/βy1−y=[g(Φ(z),a,b)]−1/βy1−Φ(z). | (2.8) |
By L’Hospital’s rule and taking the derivatives of the numerator and the denominator of (2.8) with respect to
For tail convexity, we say that the right tail of an interval distribution is convex if
Again, write
h\left(z, a, b\right) = \mathrm{log}\left[g\left(\mathrm{\Phi }\left(z\right), a, b\right)\right], | (2.9) |
where
g\left(y, a, b\right) = \mathrm{exp}\left[h\left(z, a, b\right)\right]. | (2.10) |
By (2.9), (2.10), using (2.6) and the relationship
{g}_{y}^{'} = {[h}_{z}^{'}\left(z\right)/{\rm{ \mathsf{ ϕ} }}\left(\mathrm{z}\right)]\mathrm{e}\mathrm{x}\mathrm{p}[h({\mathrm{\Phi }}^{-1}\left(y\right), a, b)], \\ {g}_{yy}^{''} = \left[\frac{{h}_{zz}^{''}\left(z\right)}{{{\rm{ \mathsf{ ϕ} }}}^{2}\left(\mathrm{z}\right)}-\frac{{h}_{z}^{'}\left(z\right){{\rm{ \mathsf{ ϕ} }}}_{\mathrm{z}}^{'}\left(z\right)}{{{\rm{ \mathsf{ ϕ} }}}^{3}\left(\mathrm{z}\right)}+\frac{{h}_{\mathrm{z}}^{\mathrm{'}}\left(\mathrm{z}\right){h}_{\mathrm{z}}^{\mathrm{'}}\left(\mathrm{z}\right)}{{{\rm{ \mathsf{ ϕ} }}}^{2}\left(\mathrm{z}\right)}\right]\mathrm{e}\mathrm{x}\mathrm{p}\left[h\right({\mathrm{\Phi }}^{-1}\left(y\right), a, b) ]. | (2.11) |
The following lemma is useful for checking tail convexity, it follows from (2.11).
Lemma 2.3. Suppose
In this section, we focus on the case where
One can explore into a wide list of densities with different choices for
A.
B.
C.
D.D.
Densities for cases A, B, C, and D are given respectively in (3.3) (section 3.1), (A.1), (A.3), and (A5) (Appendix A). Tail behaviour study is summarized in Propositions 3.3, 3.5, and Remark 3.6. Sketches of density plots are provided in Appendix B for distributions A, B, and C.
Using the notations of section 2, we have
By (2.5), we have
\mathrm{log}\left(\frac{{U}_{1}}{{U}_{2}}\right) = \frac{{-z}^{2}+2az-{a}^{2}+{b}^{2}{z}^{2}}{2{b}^{2}} | (3.1) |
= \frac{{-\left(1-{b}^{2}\right)\left(z-\frac{a}{1-{b}^{2}}\right)}^{2}+\frac{{b}^{2}}{1-{b}^{2}}{a}^{2}}{2{b}^{2}}\text{.} | (3.2) |
Therefore, we have
g\left(\mathrm{y}, a, b\right) = \frac{1}{b}\mathrm{e}\mathrm{x}\mathrm{p}\left\{\frac{{-\left(1-{b}^{2}\right)\left(z-\frac{a}{1-{b}^{2}}\right)}^{2}+\frac{{b}^{2}}{1-{b}^{2}}{a}^{2}}{2{b}^{2}}\right\}\text{.} | (3.3) |
Again, using the notations of section 2, we have
g\left(y, p, \rho \right) = \sqrt{\frac{1-\rho }{\rho }}\mathrm{e}\mathrm{x}\mathrm{p}\{-\frac{1}{2\rho }{\left[{\sqrt{1-\rho }{\mathrm{\Phi }}^{-1}\left(y\right)-\mathrm{\Phi }}^{-1}\left(p\right)\right]}^{2}+\frac{1}{2}{\left[{\mathrm{\Phi }}^{-1}\left(y\right)\right]}^{2}\}\text{, } | (3.4) |
where
Proposition 3.1. Density (3.3) is equivalent to (3.4) under the relationships:
a = \frac{{\Phi }^{-1}\left(p\right)}{\sqrt{1-\rho }} \ \ \text{and}\ \ b = \sqrt{\frac{\rho }{1-\rho }}. | (3.5) |
Proof. A similar proof can be found in [19]. By (3.4), we have
g\left(y, p, \rho \right) = \sqrt{\frac{1-\rho }{\rho }}\mathrm{e}\mathrm{x}\mathrm{p}\{-\frac{1-\rho }{2\rho }{\left[{{\mathrm{\Phi }}^{-1}\left(y\right)-\mathrm{\Phi }}^{-1}\left(p\right)/\sqrt{1-\rho }\right]}^{2}+\frac{1}{2}{\left[{\mathrm{\Phi }}^{-1}\left(y\right)\right]}^{2}\} |
= \frac{1}{b}\mathrm{exp}\left\{-\frac{1}{2}{\left[\frac{{\Phi }^{-1}\left(y\right)-a}{b}\right]}^{2}\right\}\mathrm{e}\mathrm{x}\mathrm{p}\left\{\frac{1}{2}{\left[{\mathrm{\Phi }}^{-1}\left(y\right)\right]}^{2}\right\} |
= {U}_{1}/{(bU}_{2}) = g(y, a, b)\text{.} |
The following relationships are implied by (3.5):
\rho = \frac{{b}^{2}}{1{+b}^{2}}, | (3.6) |
a = {\Phi }^{-1}\left(p\right)\sqrt{1+{b}^{2}}\text{.} | (3.7) |
Remark 3.2. The mode of
\frac{\sqrt{1-\rho }}{1-2\rho }{\mathrm{\Phi }}^{-1}\left(p\right) = \frac{\sqrt{1+{b}^{2}}}{1-{b}^{2}}{\mathrm{\Phi }}^{-1}\left(p\right) = \frac{a}{1-{b}^{2}}. |
This means
Proposition 3.3. The following statements hold for
(ⅰ)
(ⅱ)
(ⅲ) If
Proof. For statement (ⅰ), we have
Consider statement (ⅱ). First by (3.3), if
{\left[g\left(\mathrm{\Phi }\left(\mathrm{z}\right), a, b\right)\right]}^{-1/\beta } = {b}^{1/\beta }\mathrm{e}\mathrm{x}\mathrm{p}(-\frac{{\left({b}^{2}-1\right)z}^{2}+2az-{a}^{2}}{2\beta {b}^{2}}) | (3.8) |
By taking the derivative of (3.8) with respect to
-\left\{\partial {\left[g\left(\mathrm{\Phi }\left(\mathrm{z}\right), a, b\right)\right]}^{-\frac{1}{\beta }}/\partial z\right\}/{\rm{ \mathsf{ ϕ} }}\left(\mathrm{z}\right) = \sqrt{2\pi }{b}^{\frac{1}{\beta }}\frac{\left({b}^{2}-1\right)z+a}{\beta {b}^{2}}\mathrm{e}\mathrm{x}\mathrm{p}(-\frac{{\left({b}^{2}-1\right)z}^{2}+2az-{a}^{2}}{2\beta {b}^{2}}+\frac{{z}^{2}}{2})\text{.} | (3.9) |
Thus
\left\{\partial {\left[g\left(\mathrm{\Phi }\left(\mathrm{z}\right), a, b\right)\right]}^{-\frac{1}{\beta }}/\partial z\right\}/{\rm{ \mathsf{ ϕ} }}\left(\mathrm{z}\right) = -\sqrt{2\pi }{b}^{\frac{1}{\beta }}\frac{\left({b}^{2}-1\right)z+a}{\beta {b}^{2}}\mathrm{e}\mathrm{x}\mathrm{p}(-\frac{{\left({b}^{2}-1\right)z}^{2}+2az-{a}^{2}}{2\beta {b}^{2}}+\frac{{z}^{2}}{2})\text{.} | (3.10) |
Thus
For statement (ⅲ), we use Lemma 2.3. By (2.9) and using (3.2), we have
h\left(z, a, b\right) = \mathrm{log}\left(\frac{{U}_{1}}{{bU}_{2}}\right) = \frac{{-\left(1-{b}^{2}\right)\left(z-\frac{a}{1-{b}^{2}}\right)}^{2}+\frac{{b}^{2}}{1-{b}^{2}}{a}^{2}}{2{b}^{2}}-\mathrm{l}\mathrm{o}\mathrm{g}\left(b\right)\text{.} |
When
Remark 3.4. Assume
li{m}_{z⤍+\infty }-\left\{{\partial \left[g\left(\mathrm{\Phi }\left(\mathrm{z}\right), a, b\right)\right]}^{-\frac{1}{\beta }}/\partial z\right\}/{\rm{ \mathsf{ ϕ} }}\left(\mathrm{z}\right) |
is
For these distributions, we again focus on their tail behaviours. A proof for the next proposition can be found in Appendix A.
Proposition 3.5. The following statements hold:
(a) Density
(b) The tailed index of
Remark 3.6. Among distributions A, B, C, and Beta distribution, distribution B gets the highest tailed index of 1, independent of the choices of
In this section, we assume that
First, we consider a simple case, where risk outcome
y = \mathrm{\Phi }\left(v+bs\right), | (4.1) |
where
Given a sample
LL = \sum _{i = 1}^{n}\left\{\mathrm{log}f\left(\frac{{z}_{i}-{v}_{i}}{b}\right)-\mathrm{l}\mathrm{o}\mathrm{g}{\rm{ \mathsf{ ϕ} }}\left({z}_{i}\right)-logb\right\}\text{, } | (4.2) |
where
Recall that the least squares estimators of
SS = \sum _{i = 1}^{n}{({z}_{i}-{v}_{i})}^{2} | (4.3) |
has a closed form solution given by the transpose of
{\rm{X}} = \left\lceil {\begin{array}{*{20}{c}} {\begin{array}{*{20}{c}} {1\;\;{x_{11}} \ldots {x_{k1}}}\\ {1\;\;{x_{12}} \ldots {x_{k2}}} \end{array}}\\ \ldots \\ {1\;\;{x_{1n}} \ldots {x_{kn}}} \end{array}} \right\rceil , {\rm{Z}} = \left\lceil {\begin{array}{*{20}{c}} {\begin{array}{*{20}{c}} {{z_1}}\\ {{z_2}} \end{array}}\\ \ldots \\ {{z_n}} \end{array}} \right\rceil . |
The next proposition shows there exists an analytical solution for the parameters of model (4.1).
Proposition 4.1. Given a sample
Proof. Dropping off the constant term from (4.2) and noting
LL = -\frac{1}{2{b}^{2}}\sum _{i = 1}^{n}{({z}_{i}-{v}_{i})}^{2}-nlogb, | (4.4) |
Hence the maximum likelihood estimates
Next, we consider the general case of model (1.1), where the risk outcome
y = \mathrm{\Phi }[v+ws], | (4.5) |
where parameter
(a)
(b)
Given a sample
LL = \sum _{i = 1}^{n}-{\frac{1}{2}[\left({z}_{i}-{v}_{i}\right)}^{2}/{w}_{i}^{2}-{u}_{i}], | (4.6) |
LL = \sum _{i = 1}^{n}\{-\left({z}_{i}-{v}_{i}\right)/{w}_{\mathrm{i}}-2\mathrm{log}[1+\mathrm{e}\mathrm{x}\mathrm{p}[-({z}_{i}-{v}_{i})/{w}_{i}]-{u}_{i}\}, | (4.7) |
Recall that a function is log-concave if its logarithm is concave. If a function is concave, a local maximum is a global maximum, and the function is unimodal. This property is useful for searching maximum likelihood estimates.
Proposition 4.2. The functions (4.6) and (4.7) are concave as a function of
Proof. It is well-known that, if
For (4.7), the linear part
In general, parameters
Algorithm 4.3. Follow the steps below to estimate parameters of model (4.5):
(a) Given
(b) Given
(c) Iterate (a) and (b) until a convergence is reached.
With the interval distributions introduced in this paper, models with a random effect can be fitted for a continuous risk outcome by maximum likelihood approaches assuming an interval distribution. These models provide an alternative regression tool to the Beta regression model and fraction response model, and a tool for tail risk assessment as well.
Authors are very grateful to the third reviewer for many constructive comments. The first author is grateful to Biao Wu for many valuable conversations. Thanks also go to Clovis Sukam for his critical reading for the manuscript.
We would like to thank you for following the instructions above very closely in advance. It will definitely save us lot of time and expedite the process of your paper's publication.
The views expressed in this article are not necessarily those of Royal Bank of Canada and Scotiabank or any of their affiliates. Please direct any comments to Bill Huajian Yang at h_y02@yahoo.ca.
[1] | K. Murphy, Immunobiology, Garland Science, 2012. |
[2] | J. Gameiro, P. Nagib and L. Verinaud, The thymus microenvironment in regulating thymocyte differentiation, Cell Adhes. Migr., 4 (2010), 382–390. |
[3] | B. Alberts, A. Johnson, J. Lewis, et al., Molecular Biology of the Cell, Garland Science, 2002. |
[4] | A. Corthday, How do regulatory T cells work?, Scand. J. Immunol., 70 (2009), 326–336. |
[5] | D. L. Farber, N. A. Yudanin and N. P. Restifo, Human memory T cells: Generation, compartmentalization and homeostasis, Nat. Rev. Immunol., 14 (2014), 24–35. |
[6] | Y. Takahama, Journey through the thymus: Stromal guides for T-cell development and selection, Nat. Rev. Immunol., 6 (2006), 127–135. |
[7] | C. H. Bassing, W. Swat and F. W. Alt, The mechanism and regulation of chromosomal V(D)J recombination, Cell, 109 (2002), S45–S55. |
[8] | D. Mason, A very high level of crossreactivity is an essential feature of the T-cell receptor, Trends Immunol., 19 (1998), 395–404. |
[9] | J. Nicolić-Žugić, M. K. Slifka and I. Messaoudi, The many important facets of T-cell repertoire diversity, Nat. Rev. Immunol., 4 (2004), 123–132. |
[10] | D. J. Laydon, C. R. M. Bangham and B. Asquith, Estimating T-cell repertoire diversity: Limitations of classical estimators and a new approach, Philos. Trans. R. Soc. B, 370 (2015), 1–11. |
[11] | M. S. Chaudhry, E. Velardi, J. A. Dudakov, et al., Thymus: The next (re)generation, Immunol. Rev., 271 (2016), 56–71. |
[12] | G. G. Steinmann, B. Klaus and H. K. Müller-Hermelink, The involution of the ageing human thymic epithelium is independent of puberty, Scand. J. Immunol., 22 (1985), 563–575. |
[13] | A. Globerson and R. B. Effros, Aging of lymphocytes and lymphocytes in the aged, Immunol. Today, 21 (2000), 515–521. |
[14] | A. L. Gruver, L. L. Hudson and J. D. Sempowski, Immunosenescence of aging, J. Pathol., 211 (2007), 144–156. |
[15] | D. P. Shanley, D. Aw, N. R. Manley, et al., An evolutionary perspective on the mechanisms of immunosenescence, Trends Immunol., 30 (2009), 374–381. |
[16] | A. L. Gruver and G. D. Sempowski, Cytokines, leptin, and stress-induced thymic atrophy, J. Leukocyte Biol., 84 (2008), 915–923. |
[17] | J. Dooley and A. Liston. Molecular control over thymic involution: From cytokines and microRNA to aging and adipose tissue, Eur. J. Immunol., 42 (2012), 1073–1079. |
[18] | H. Selye, Thymus and the adrenals in the response of the organ to injuries and intoxications, Br. J. Exper. Pathol., 17 (1936), 234–248. |
[19] | W. Savino, The thymus is a common target organ in infectious diseases, PLoS Pathog., 2 (2006), e62. |
[20] | S. D. Wang, K. J. Huang, Y. S. Lin, et al., Sepsis-induced apoptosis of the thymocytes in mice, J. Immunol., 152 (1994), 5014–5021. |
[21] | W. W Grody, S. Fliegiel and F. Naeim, Thymus involution in the acquired immunodeficiency syndrome, Am. J. Clin. Pathol., 84 (1985), 85–95. |
[22] | W. Savino, M. Dardenne, L. A. Velloso, et al., The thymus is a common target in malnutrition and infection, Br. J. Nutr., 98 (2007), S11–S16. |
[23] | C. L. Mackall, T. A. Fleischer, M. R. Brown, et al., Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy, New Engl. J. Med., 332 (1995), 143–149. |
[24] | J. Storek, R. P. Witherspoon and R. Storb, T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life, Bone Marrow Transplant., 16 (1995), 413–425. |
[25] | A. L. Zoller, F. J. Schnell and G. J. Kersh, Murine pregnancy leads to reduced proliferation of maternal thymocytes and decreased thymic emigration, Immunology, 121 (2007), 207–215. |
[26] | T. A. Tibbetts, F. DeMayo, S. Rich, et al., Progesterone receptors in the thymus are required for thymic involution during pregnancy and for normal fertility, PNAS, 96 (1999), 12021–12026. |
[27] | A. G. Rijhsinghani, K. Thompson and S. K. Bhatia, Estrogen blocks early T cell development in the thymus, Am. J. Reprod. Immunol., 36 (1996), 269–277. |
[28] | J. D. Ashwell, F. W. M. Lu and M. S. Vacchio, Glucocorticoids in T cell development and function, Annu. Rev. Immunol., 18 (2000), 309–345. |
[29] | D. A. da Cruz, J. S. Silva, V. C. de Almeida, et al., Altered thymocyte migration during experimental acute trypanosoma cruzi infection: Combined role of fibronectin and the chemokines CXCL12 and CCL4, Eur. J. Immunol., 36 (2006), 1486–1493. |
[30] | S. K. Stanley, J. M. McCune, H. Kaneshima, et al., Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse, J. Exper. Med., 178 (1993), 1151–1163. |
[31] | M. G. Durdov, O. Springer, V. Ćapkun, et al., The grade of acute thymus involution in neonates correlates with the duration of acute illness and with the percentage of lymphocytes in peripheral blood smear, Biol. Neonate, 83 (2003), 229–234. |
[32] | J. van Baarlen, H. J. Schuurman, R. Reitsma, et al., Acute thymuc involution during infancy and childhood: Immunohistology of the thymus and peripheral lymphoid tissues after acute illness, Pediat. Pathol., 19 (1989), 261–275. |
[33] | E. Juretić, A. Juretić, B. Užarević, et al., Alterations in lymphocyte phenotype of preterm infected newborns, Biol. Neonate, 80 (2001), 223–227. |
[34] | S. M. Falkenberg, C. Johnson, F.V. Bauermann, et al., Changes observed in the thymus and lymph nodes 14 days after exposure to BVDV field strains of enhanced or typical virulence in neonatal calves, Vet. Immunol. Immunopathol., 160 (2014), 70–80. |
[35] | J. P. L. Rangel, C. S. Galan-Enriquez, M. López-Medina, et al., Bacterial clearance reverses a skewed T-cell repertoire induced by Salmonella infection, Immun., Inflammation Dis., 3 (2015), 209–223. |
[36] | S. Yovino, L. Kleinberg, S. A. Grossman, et al., The etiology of treatment-related lymphopenia in patients with malignant gliomas: Modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells, Cancer Invest., 31 (2013), 140–144. |
[37] | J. S. Mendez, A. Govindan, J. Leong, et al., Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma, J. Neuro-Oncol., 127 (2016), 329–335. |
[38] | J. L. Campian, X. Ye, M.Brock, et al., Treatment-related lymphopenia in patients with stage Ⅲ non-small-cell lung cancer, Cancer Invest., 31 (2013), 183–188. |
[39] | S. S. Long, Laboratory manifestations of infectious disease, in Principles and Practice of Pediatric Infectious Diseases, 4th edition, Elsevier, (2012), 1400–1412. |
[40] | S. M. Ciupe, B. H. Devlin, M. L. Markert, et al., The dynamics of T-cell receptor repertoire diversity following thymus transplantation for digeorge anomaly, PLoS Comput. Biol., 5 (2009), e1000396. |
[41] | J. F. Purton, J. A. Monk, D. R. Liddicoat, et al., Expression of the glucocorticoid receptor from the 1A promotor correlates with T lymphocyte sensitivity to glucocorticoid–induced cell death, J. Immunol., 173 (2004), 3816–3824. |
[42] | F. K. Kong, C. L. H. Chen and M. D. Cooper, Reversible disruption of thymic function by steroid treatment, J. Immunol., 168 (2002), 6500–6505. |
[43] | J. A. Guevara Patiño, M. W. Marino, V. N. Ivanov, et al., Sex steroids induce apoptosis of CD8+ CD4+ double positive thymocytes via TNF-\alpha, Eur. J. Immunol., 30 (2000), 2586–2592. |
[44] | P. L. Choyke, R. K. Zemon, J. E. Gootenberg, et al., Thymic atrophy and regrowth in response to chemotherapy: CT evaluation, Am. J. Roentgenol., 149 (1987), 269–272. |
[45] | M. Cohen, C. A. Hill, A. Cangir, et al., Thymic rebound after treatment of childhood tumors, Am. J. Roentgenol., 135 (1980), 151–156. |
[46] | D. E. DeFriend, J. M. Coote, M. P. Williams, et al., Thymic enlargement in an adult following a severe infection, Clin. Radiol., 56 (2001), 331–333. |
[47] | D. W. Gelfand, A. S. Goldman, E. J. Law, et al., Thymic hyperplasia in children recovering from thermal burns, J. Trauma, 12 (1972), 813–817. |
[48] | L. M. Bradley, L. Haynes and S. L. Swain, IL-7: Maintaining T-cell memory and achieving homeostasis, Trends Tmmunol., 26 (2005), 172–176. |
[49] | J. T. Tan, E. Dudl, E. LeRoy, et al., IL-7 is critical for homeostatic proliferation and survival of naive T cells, Proc. Natl. Acad. Sci., 98 (2001), 8732–8737. |
[50] | L. Vivien, C. Benoist and D. Mathis, T lymphocytes need IL-7 but not IL-4 or IL-6 to survive in vivo, Int. Immunol., 13 (2001), 763–768. |
[51] | T. J. Fry and C. L. Mackall, The many faces of IL-7: From lymphopoesis to peripheral T cell maintenance, J. Immunol., 174 (2005), 6571–6576. |
[52] | S. Xu and T. Chou, Immigration-induced phase transition in a regulated multispecies birth-death process, J. Phys. A: Math. Theor., 51 (2018), 425602. |
[53] | J. Hataye, J. J. Moon, A. Khoruts, et al., Naïve and memory CD4+ T cell survival controlled by clonal abundance, Science, 312 (2006), 114–116. |
[54] | R. Dessalles, M. D'Orsogna and T. Chou, Exact steady-state distributions of multispecies birth–death–immigration processes: Effects of mutations and carrying capacity on diversity, J. Stat. Phys., 173 (2018), 182–221. |
[55] | L. Westera, V. van Hoeven, J. Drylewicz, et al., Lymphocyte maintenance during healthy aging requires no substantial alterations in cellular turnover, Aging Cell, 14 (2015), 219–227. |
[56] | H. S. Robins, P. V. Campregher, S. K. Srivastava, et al., Comprehensive assessment of T-cell receptor \beta-chain diversity in \alpha \beta T cells, Blood, 114 (2009), 4099–4107. |
[57] | G. Lythe, R. E. Callard, R. L. Hoare, et al., How many TCR clonotypes does a body maintain?, J. Theor. Biol., 389 (2016), 214–224. |
[58] | S. Lewkiewicz, Y. L. Chuang and T. Chou, A mathematical model of the effects of aging on naive T cell populations and diversity, Bull. Math. Biol., 81 (2019), 2783–2817. |
[59] | N. Vrisekoop, I. den Braber, A. B. de Boer, et al., Sparse production but preferential incorporation of recently produced naive T-cells in the human peripheral pool, Proc. Natl. Acad. Sci., 105 (2008), 6115–6120. |
[60] | R. J. de Boer and A. S. Perelson, Quantifying T lymphocyte turnover, J. Theor. Biol., 327 (2013), 45–87. |